Gene Expression Study in Psychiatric Conditions
Part of Mental health clinical trials.
This research study examines how certain genes are expressed (turned on or off) in people with psychiatric conditions like bipolar disorder, depression, panic disorder, OCD, or schizophrenia. The study compares gene expression in patients with these conditions to healthy volunteers to better understand what happens at a biological level.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–55 years old
- If female, must be in the mid-luteal phase of your menstrual cycle (roughly days 19–23 of your cycle) when you enroll
- Either newly diagnosed with one of five psychiatric conditions (bipolar disorder type I or II, panic disorder, depression, OCD, or schizophrenia) and never taken psychiatric medications, OR haven't taken any psychiatric medications for at least 6 months
- No current use of medications that suppress your immune system, antibiotics, or hormone replacement therapy
- No active infections or infections resolved less than 3 weeks ago
- No serious medical conditions like autoimmune diseases, other major illnesses, or untreated psychiatric conditions besides your primary diagnosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at certain immune cells in the blood of people with bipolar disorder compared with healthy individuals. The goal is to see if these cells might be related to the condition, which could help in future treatments.
This study is developing more personalized treatments for schizophrenia, depression, or bipolar disorder. It may help find the best treatment approach for your specific situation.
This study looks for biological markers in the blood or spinal fluid that might predict how well a new psychiatric treatment will work. If you have a psychiatric condition that hasn't improved with previous treatments, this research could help find better ways to match treatments to individuals in the future.
This study collects information about mental health symptoms and body/genetic samples to better understand how different mental health conditions are related. Some people may also have brain scans (PET or MRI) if they can safely complete them.
This study looks at genes, blood/brain proteins, and gut microbes in people with obsessive-compulsive disorder (OCD). It may help researchers understand what drives OCD and how treatments could be better tailored in the future.
This trial studies whether genes (using a saliva sample) can help explain why some young people feel more “disinhibited” after taking antidepressants like SSRIs. If you’ve had depression, anxiety, or OCD and have used an SSRI, your information and genetics may help improve how antidepressants are chosen and monitored.
Hear when a new Schizophrenia Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.